95937

Neuromuscular junction testing (repetitive stimulation, paired stimuli), each nerve, any 1 method

CPT code 95937 describes the procedure for neuromuscular junction (NMJ) testing, a specialized electrodiagnostic study used to evaluate the functional and structural integrity of the physiological synapse between the terminal motor nerve branch and the muscle fiber. This testing is primarily achieved through repetitive nerve stimulation (RNS) or paired stimuli techniques. The fundamental objective is to diagnose, categorize, or monitor disorders of neuromuscular transmission, such as Myasthenia Gravis (MG), Lambert-Eaton myasthenic syndrome (LEMS), and botulism. During the procedure, the provider carefully places surface recording electrodes over the belly of a specific target muscle, commonly the abductor digiti minimi in the hand, the trapezius in the shoulder, the anconeus in the arm, or the nasalis in the face. The provider then applies repetitive electrical stimulation to the corresponding motor nerve supplying that muscle at varying, precisely controlled frequencies. The protocol typically commences with a slow stimulation rate of 2 to 3 Hertz. In specific clinical scenarios, high-frequency stimulation (up to 50 Hertz) or post-exercise facilitation techniques are deployed. The resulting compound muscle action potentials (CMAPs) are meticulously recorded and analyzed for amplitude and area fluctuations. A decremental response, defined as a significant drop in CMAP amplitude (usually greater than 10 percent from the first to the fourth or fifth electrical response), strongly indicates a postsynaptic neuromuscular junction defect, typical of Myasthenia Gravis. Conversely, a substantial incremental response, characterized by a significant increase in CMAP amplitude following high-frequency stimulation or maximum voluntary isometric contraction, suggests a presynaptic defect, highly characteristic of Lambert-Eaton myasthenic syndrome. The procedure demands high technical precision; the provider must strictly control skin temperature (maintaining it above 32 degrees Celsius) because a colder temperature can artificially mask myasthenic decremental defects, leading to false-negative results. The provider must also aggressively minimize movement artifacts. CPT code 95937 is reported per nerve evaluated, regardless of whether repetitive stimulation or paired stimuli methods are utilized. Comprehensive documentation must include the specific nerve or nerves tested, the stimulation frequencies utilized, baseline and subsequent measured CMAP amplitudes, skin temperature recordings, and the final clinical interpretation of the findings in the direct context of the patient presenting neuromuscular symptoms.

Clinical Indications

  • Suspected or confirmed Myasthenia Gravis
  • Evaluation of Lambert-Eaton myasthenic syndrome
  • Assessment of suspected botulism intoxication
  • Evaluation of unexplained generalized weakness, fatigue, or bulbar symptoms such as diplopia, ptosis, dysphagia, and dysarthria that fluctuate throughout the day
  • Differentiation between presynaptic and postsynaptic neuromuscular junction disorders
  • Monitoring therapeutic response in known neuromuscular junction diseases

Procedure Steps

  1. The patient is positioned comfortably, and the limb or area to be tested is immobilized to prevent movement artifacts during repetitive stimulation.
  2. Skin temperature is measured and maintained above 32 degrees Celsius, as cooler temperatures can artificially mask decremental responses.
  3. Recording surface electrodes are placed over the belly of the muscle to be tested with the reference electrode placed over the tendon.
  4. A stimulating electrode is positioned over the corresponding motor nerve supplying the muscle.
  5. A baseline supramaximal single stimulus is applied to obtain the initial compound muscle action potential and ensure optimal electrode placement.
  6. A train of 5 to 10 electrical stimuli is delivered at a slow frequency (usually 2 to 3 Hertz).
  7. The amplitude and area of the resulting compound muscle action potentials are measured, specifically calculating the percentage change from the first to the fourth or fifth potential.
  8. If a presynaptic defect is suspected, a brief period of maximum voluntary muscle contraction (10 to 30 seconds) is performed by the patient, or high-frequency stimulation is applied.
  9. Immediately following the exercise or high-frequency stimulation, slow-frequency stimulation is repeated to assess for post-exercise facilitation or post-exercise exhaustion.
  10. The provider reviews the electrophysiological data, rules out technical artifacts, and compiles a formal report detailing the findings for each nerve tested.

Coding Guidelines

  • Report CPT 95937 for each distinct nerve tested. If multiple nerves are tested, report the code with multiple units corresponding to the number of nerves evaluated.
  • Do not report 95937 for routine nerve conduction studies; use the appropriate NCS codes (95907-95913) for standard motor and sensory conduction tests.
  • When performed with electromyography or nerve conduction studies, ensure documentation clearly separates the neuromuscular junction testing results from the other electrodiagnostic findings.
  • Append modifier 26 for the professional component if the provider only interprets the test in a facility setting.
  • Append modifier TC for the technical component if billing only for the equipment, supplies, and technician time.
  • Documentation must specify the nerves tested, the method used, and the interpretation of the results to support medical necessity.
  • Modifier 59 or X-modifiers may be required if payer edits bundle this with another procedure performed on the same date, provided a distinct and separate service was rendered.

Associated ICD-10 Codes